Log in | Jump |

Tags

This thing was constructed on September 30, 2011, and it was categorized as Uncategorized.
You can follow comments through the RSS 2.0 feed. You can skip to the end and leave a comment. Trackbacks are not allowed.
Ironwood's IBS drug advances in Europe; Nature highlights strategies to
FierceBiotech
News | Follow @RyanMFierce @MaureenFierce: Google AdWords ban keeps drug savings from US poor. Article | Follow @MaureenFierce > Ironwood Pharmaceuticals' ($IRWD) European partner Almirall SA has submitted an application for EU approval of linaclotide,

and more »

This thing was constructed by
.


You can follow comments through the RSS 2.0 feed. You can skip to the end and leave a comment. Trackbacks are not allowed.

Post a Comment

Your email is never published nor shared. Required fields are marked *

*
*